• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类中凝血因子X激活的检测。

Detection of factor X activation in humans.

作者信息

Bauer K A, Kass B L, ten Cate H, Bednarek M A, Hawiger J J, Rosenberg R D

机构信息

Charles A. Dana Research Institute, Beth Israel Hospital, Boston, MA 02215.

出版信息

Blood. 1989 Nov 1;74(6):2007-15.

PMID:2804345
Abstract

A sensitive radioimmunoassay (RIA) for the fragment that is liberated from factor X when this zymogen is activated by factor VII/VIIa-tissue factor or factor IXa was developed. Antisera were raised in rabbits to a synthetic 15 amino acid peptide containing the COOH-terminal sequence of the activation fragment coupled to bovine serum albumin with glutaraldehyde. The reactivity of the antibody population obtained toward the factor X zymogen was negligible (less than 1/36,000 that of the activation peptide on a molar basis). However, because other plasma constituents contributed to a nonspecific basal signal in the RIA, a procedure by which the peptide could be reproducibly extracted from plasma was developed. The mean level of this species in normal individuals younger than the age of 40 was 66.4 pmol/L, and elevations up to 550 pmol/L were observed in patients with evidence of disseminated intravascular coagulation. The validity of these measurements of factor X activation is supported by the fact that the RIA signal migrates on reverse-phase high pressure liquid chromatography in a manner identical to that of the native peptide and can be quantitatively recovered. The mean concentration of the activation fragment was markedly decreased to 25.7 pmol/L in patients with hereditary factor VII deficiency (P = .0001 v normal controls), whereas the mean level in subjects with factor VIII deficiency was 61.1 pmol/L (P greater than .1 v normal controls). These data indicate that the basal (ie, in the absence of thrombosis or provocative stimuli) levels of FXP under in vivo conditions result mainly from the activity of the extrinsic pathway.

摘要

开发了一种灵敏的放射免疫测定法(RIA),用于检测当凝血因子X被凝血因子VII/VIIa-组织因子或凝血因子IXa激活时释放的片段。用含有激活片段COOH末端序列的15个氨基酸合成肽与牛血清白蛋白通过戊二醛偶联,在兔体内制备抗血清。所获得的抗体群体对凝血因子X酶原的反应性可忽略不计(摩尔基础上小于激活肽的1/36,000)。然而,由于其他血浆成分在RIA中产生非特异性基础信号,因此开发了一种可从血浆中可重复提取该肽的方法。40岁以下正常个体中该物质的平均水平为66.4 pmol/L,在有弥散性血管内凝血证据的患者中观察到高达550 pmol/L的升高。凝血因子X激活这些测量值的有效性得到以下事实的支持:RIA信号在反相高压液相色谱上的迁移方式与天然肽相同,并且可以定量回收。遗传性凝血因子VII缺乏症患者中激活片段的平均浓度显著降低至25.7 pmol/L(与正常对照组相比,P = .0001),而凝血因子VIII缺乏症患者中的平均水平为61. pmol/L(与正常对照组相比,P大于.1)。这些数据表明,体内条件下FXP的基础(即无血栓形成或激发刺激)水平主要源于外源性途径的活性。

相似文献

1
Detection of factor X activation in humans.人类中凝血因子X激活的检测。
Blood. 1989 Nov 1;74(6):2007-15.
2
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.凝血因子IXa-凝血因子VIIIa-细胞表面复合物对体内凝血机制的基础激活没有作用。
Blood. 1992 Apr 15;79(8):2039-47.
3
Detection of protein C activation in humans.人类中蛋白C活化的检测。
J Clin Invest. 1984 Dec;74(6):2033-41. doi: 10.1172/JCI111626.
4
Regulation of the initiation of coagulation by factor VII.
Haemostasis. 1983;13(3):150-5. doi: 10.1159/000214720.
5
An alternative extrinsic pathway of human blood coagulation.人类血液凝固的另一种外源性途径。
Blood. 1982 Dec;60(6):1353-8.
6
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.人血液中活化的因子IX-抗凝血酶III复合物:通过酶联差异抗体免疫测定法定量并测定体内半衰期。
J Lab Clin Med. 1991 Oct;118(4):317-25.
7
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.酶原因子VII对凝血酶生成的抑制作用:对用因子VIIa治疗A型血友病的启示。
Blood. 2000 Feb 15;95(4):1330-5.
8
Determinants of plasma factor VIIa levels in humans.
Blood. 1995 Oct 15;86(8):3021-5.
9
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.血友病作为凝血组织因子途径的缺陷:因子VIII和IX对连续流动反应器中因子X激活的影响。
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7623-7. doi: 10.1073/pnas.87.19.7623.
10
Measurement of basal levels of factor VIIa in hemophilia A and B patients.血友病A和B患者中凝血因子VIIa基础水平的测量。
Blood. 1992 Jul 1;80(1):25-8.

引用本文的文献

1
Soluble Membrane Attack Complex: Biochemistry and Immunobiology.可溶性膜攻击复合物:生物化学与免疫生物学。
Front Immunol. 2020 Nov 10;11:585108. doi: 10.3389/fimmu.2020.585108. eCollection 2020.
2
Thrombin Generation Biomarkers Decline With Parenteral Anticoagulation-An Overlooked Means of Anticoagulation Monitoring?凝血酶生成生物标志物随胃肠外抗凝治疗而下降——一种被忽视的抗凝监测手段?
Clin Appl Thromb Hemost. 2018 Jul;24(5):708-717. doi: 10.1177/1076029617746506. Epub 2018 Feb 13.
3
Prochemerin cleavage by factor XIa links coagulation and inflammation.
因子 XIa 对 prochelmerin 的裂解将凝血和炎症联系起来。
Blood. 2018 Jan 18;131(3):353-364. doi: 10.1182/blood-2017-07-792580. Epub 2017 Nov 20.
4
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.Xa 因子介导内皮细胞钙离子内流,并受狼疮和/或抗磷脂综合征患者 IgG 的增强。
Sci Rep. 2017 Sep 7;7(1):10788. doi: 10.1038/s41598-017-11315-9.
5
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.内皮细胞蛋白 C 受体介导的因子 VIIa 重分布和组织水平蓄积。
J Thromb Haemost. 2012 Nov;10(11):2383-91. doi: 10.1111/j.1538-7836.2012.04917.x.
6
Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.单核细胞和血小板衍生微粒对凝血酶生成、纤维蛋白形成和稳定性的差异贡献。
J Thromb Haemost. 2011 Nov;9(11):2251-61. doi: 10.1111/j.1538-7836.2011.04488.x.
7
Alternatively spliced isoforms of tissue factor pathway inhibitor.组织因子途径抑制物的剪接异构体。
Thromb Res. 2010 Apr;125 Suppl 1:S52-6. doi: 10.1016/j.thromres.2010.01.038. Epub 2010 Feb 21.
8
FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men.在健康男性中,FVII、FVIIa 和外源性途径激活的下游标志物因 EPCR Ser219Gly 变异体而不同。
Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1968-74. doi: 10.1161/ATVBAHA.109.191551. Epub 2009 Aug 20.
9
The role of tissue factor and factor VIIa in hemostasis.组织因子和因子VIIa在止血中的作用。
Anesth Analg. 2009 May;108(5):1447-52. doi: 10.1213/ane.0b013e31819bceb1.
10
Thrombotic preparedness in aging: a translatable construct for thrombophilias?衰老中的血栓形成易感性:一种可转化的易栓症概念?
J Thromb Thrombolysis. 2007 Dec;24(3):323-5. doi: 10.1007/s11239-007-0094-9. Epub 2007 Sep 29.